Magnetic resonance diffusion-weighted whole-body imaging (DWIBS) in the urinary bladder cancer diagnostics

Year & Volume - Issue: 
Authors: 
Vladimir M. Popkov, M.L. Chekhonatskaya, Viktor V. Zuev, A.N. Ponukalin, Y.E. Nikolsky
Heading: 
Article type: 
CID: 
0210
PDF File: 
Abstract: 
The purpose of the article is to identify the most characteristic and significant changes of magnetic resonance indicators in patients with the urinary bladder cancer during diffusion-weighed whole-body imaging (DWIBS). Materials: From September 2009 till April 2011 98 patients have been examined: 61 (62.2%) with morphologically verified bladder cancer and 37 (37.8%) with cystitis. Results: The study has revealed that the sensitivity of DWIBS investigation in detecting bladder cancer is 98.36%, specificity is 10.81, and the efficacy is 65.38%. Conclusions: DWIBS is an informative noninvasive method for screening diagnostics of bladder cancer, as well as for identificating suspicious areas of regional and distant metastases.
Cite as: 
Popkov VM, Chekhonatskaya ML, Zuev VV, Ponukalin AN, Nikolsky YE. Magnetic resonance diffusion-weighted whole-body imaging (DWIBS) in the urinary bladder cancer diagnostics. Russian Open Medical Journal 2012; 1: 0210.

Introduction

Primary neoplasms of the urinary bladder account for 2-6% of all tumours [1]. Due and adequate diagnostics of the urinary tract diseases still remains a complex and actual problem of ooncology [2].

Diffusion-weighted magnetic resonance tomography (DMRT) which provides functional information can be used in detection and characterization of pathological processes in the area of investigation including malignant tumours. The proposed Diffusion-Weighted Whole-Body Imaging with Background Body Signal Suppression (DWIBS) depicts the whole body volume diffusion. This new conception possesses unique characteristics, differs from standard DMRT and is capable to play an important role in screening diagnoistics of oncological diseases [3].

The aim of the study is to identify the most significant magnetic resonance (MR) iindicators and DWIBS investigation capabilities in diagnostics of the urinary bladder cancer (UBC).

 

Material and Methods

During the period from September 2009 till April 2011 there were examined 98 patients at the age of 45-81 suspected of the urinary bladder cancer: 78 males (80%) and 20 females (22%). All the patients were admitted to the Scientific Research Institute of Clinical and Fundamental Uronephrology and Urological Clinic of Saratov State Medical University. 45 patients (45.9%) complained of painful and frequent urination, 53 patients (54.1%) demonstrated the signs of macrohematuria.

Depending on the results of histological investigation the patients were divided into two groups: the basic group consisting of 61 patients (62.2%) with morphologically verified UBC (average age of 67±13 years), and comparison group consisting of 37 patients (37.8%) with cystitis (average age of 61±11 years). Depending on the UBC stage in accordance with TNM clinical classification designed by International Anticancer Alliance in 2002, the basic group was divided into four subgroups. Stage T1 of the pathological process was dfiagnosed in 33 patients (54.1%), stage T2 - in 18 patients (29.5%), stage T3 - in 7 patients (11.5%), stage T4 - in 3 patients (4.9%). All patients were performed cystoscopy and ultrasound scan.

MR investigation was performed on thre apparatus PHILIPS of 1.5 T magnetic field power with application of the "Body-array" roll for the body. The protocol of MR investigation consisted of two consequent steps. During the first step there was performed standard iinvestigation (T2WI, T1WI, T2WI with fatty tissue signal suppression in three mutually perpendicular planes and VISTA sequence in the axial plane) in order to detect preliminary tumour localization and visualize regional metastatic areas (Table 1).

 

Table 1. Features of standart MR investigation of pelvic organs

MR stage

MR plane

TR, ms

TE, ms

Fov, mm

Stage duration

T2WI

Sag, ax, cor

3500

80

320

01:38

T1WI

Sag, ax, cor

900

7

320

02:30

T2WI with f.t.s.s.

Sag, ax, cor

3500

7

320

00:56

VISTA

ax

2000

200

130

01:02

T2WI with f.t.s.s. is T2WI with fatty tissue signal suppression.

 

For adequate urinary bladdrer fulfilment an hour prior MR investigation the patients had to drink 250-300 ml of water and not to void urine for two hours before the investigation. With the catheter fixed in the urinary bladder directly prior the investigation 250-500 ml of sterile solution were injected into the urinary bladder and the catheter was overpressed.

During the second step there was performed DWIBS investigation including complete 530 mm FOV in RL direction for complete imaging at simultaneous use of less FOV in FH direction for better resolution. Parameters of DWIBS investigation are: fat suppression STIR; b-value (s/mm2) 1.00; direction of MPGs Phase, frequency and slice phase; frequency and slice; TR (ms) 10,205; TE (ms) 70; TI (ms) 180 NA; parallel imaging factor 2; halfscan factor 0.6; EPI factor 47; slice orientation Axial; no. of slices 60; slice thickness/gap (mm) 4/0; FOV (mm) 400; RFOV (%) 70; matrix 160; scan percentage 70%; actual voxel size (mm3) 2.5x3.6x4.0; calculated voxel size (mm3) 1.6x1.6x4.0; no. of signals averaged 10; scan time 7 min. 8 s.

DWIBS investigation resulted in three blocks of native axial scans visualizing the region from the upper third of the thigh up to the head with the possibility of native data processing and three-dimensional inverted image constructing (Fig. 1).

Figure 1. Sequence of formation DWIBS-image: native DWIBS-image in the axial plane (a), local 3D DWIBS-image (b), total 3D DWIBS-image (c), reversed total 3D DWIBS-image (d).

 

Results

MR semiotics of the detected bladder wall changes in patients of the basic and comparison groups is given in Table 2.

 

Table 2. MR semiotics of UBC and cystitis in routine MR investigation of the pelvis organs

No.

MR sign

Scale

UBC

Cystitis, n (%)

(n=37)

T1, n (%)

(n=33)

T2, n (%)

(n=18)

T3, n (%)

(n=7)

T4, n (%)

(n=3)

1

What bladder walls were impaired?

right

left

anterior

posterior

urocystic triangle

16 (48.4)

10 (30.3)

2 (6.1)

3 (9.1)

3 (9.1)

6 (33.3)

5 (27.8)

2 (11.1)

3 (16.7)

2 (11.1)

4 (57.1)

1 (14.3)

0 (0)

2 (28.6)

0 (0)

2 (66.7)

0 (0)

1 (33.3)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

2

Ureter ostia involvement

no

right

left

both

20 (60.6)

6 (18.2)

7 (21.2)

0 (0)

7 (38.9)

6 (33.3)

4 (22.2)

1 (5.6)

4 (57.1)

3 (42.9)

0 (0)

0 (0)

2 (66.7)

1 (33.3)

0 (0)

0 (0)

37 (100)

0 (0)

0 (0)

0 (0)

3

Number of bladder wall formations

diffuse changes

one thing

two

three

more than three

2 (6.1)

23 (69.7)

3 (9.1)

3 (9.1)

0 (0)

2 (11.1)

15 (83.3)

0 (0)

0 (0)

1 (5.6)

0 (0)

6 (85.7)

1 (14.3)
0 (0)

0 (0)

0 (0)

3 (100)

0 (0)

0 (0)

0 (0)

37 (100)

0 (0)

0 (0)

0 (0)

0 (0)

4

Bladder wall thickening

yes

no

17 (51.5)

16 (48.5)

17 (94.4)

1 (5.6)

7 (100)

0 (0)

3 (100)

0 (0)

37 (100)

0 (0)

5

Change of MR signal from bladder wall

yes

no

14 (42.4)

19 (57.6)

17 (94.4)

1 (5.6)

7 (100)

0 (0)

3 (100)

0 (0)

37 (100)

0 (0)

6

External contours of wall formations

smooth

rough

33 (100)

0 (0)

12 (66.7)

6 (33.3)

0 (0)

7 (100)

0 (0)

3 (100)

0 (0)

0 (0)

7

Regional lymph nodes (an increase of over 0.8 cm)

no

single

conglomerate

33 (100)

0 (0)

0 (0)

11 (61.1)

7 (38.9)

0 (0)

3 (42.9)

4 (57.1)

0 (0)

1 (33.3)

2 (66.7)

0 (0)

35 (94.6)

2 (5.41)

0 (0)

8

Homogeneity of the structure of bladder wall formations

yes

no

28 (84.8)

5 (15.2)

10 (55.6)

8 (44.4)

3 (42.9)

4 (57.1)

0 (0)

3 (100)

37 (100)

0 (0)

 

The analysis of the obtained data showed that independently of the pathological process stage lateral bladder walls were impaired more frequently; in stages T1, T3 and T4 - predominantly the right bladder wall: in 48.4%, 57.1% and 66.6% of the patients respectively. Diffuse bladder walls impairment was detected in cystitis.

Frequency of ureter ostia involvement was comparable in patients with stages T1, T3 and T4. At the same time frequency of ureter ostia involvement in the pathological process in patients with stage T2 of UBC was significantly higher and reached 61.1%. Independently of the stage there prevailed solitary bladder wall formations.

With advancing of the stage of tghe disease frequency of occurance of local bladder wall thickening in the area of the pathological formation increased: in T1 – 51.5%, in T2 – 94.4%, in T3 and T4 - 100%. Change of MR bladder wall signal was detected in 42.4% of patients with stage T1, in 94.4% patients with stage T2, in 100% of patients with stages T3 and T4 of the disease. The same tendency was detected when evaluating the formation structure homogenity and enlarged regional lymphatic nodes detection frequency. Regularity of external bladder wall contours in stage T1 was 100%. In stages T3 and T4 external bladder walls in all cases were irregular which corresponded to the verified stages of the pathological process. False signs of spread into the paravesical fat were detected in 6 patients (33.3%) with stage T2. However, in routine MR investigation the possibility to evaluate distant changes in patients with UBC was lacking.

Later comparison and native T2WI with high resolution and images of DWIBS investigation were carried out. Detection of areas with increased signal on native images and with decreased signal on three-dimensional inverted images was the criterion of DWIBS images evaluation. MR signal increase during native DWIBS investigation was normally detected from the brain structures, salivary glands, tonsils, spleen, gallbladder and small intestine (Fig. 2).

 

Figure 2. Reversed total 3D DWIBS-image in healthy subject (a) and UBC patients (b). The arrow indicates area of low power signal corresponding to UBC.

 

The data obtained during DWIBS investigation are given in Table 3. MR signal increase both from the pathological urinary bladder formation and regional and distal lymphatic nodes swas detected in 60 patients (98.4%) of the basic group.

 

Table 3. MR semiotics of UBC and cystitis in DWIBS investigation

No.

MR sign

Scale

UBC

Cystitis, n (%)

(n=37)

T1, n (%)

(n=33)

T2, n (%)

(n=18)

T3, n (%)

(n=7)

T4, n (%)

(n=3)

1

MR signal increase from urinary bladder wall

yes

no

32 (97.0)

1 (3.0)

18 (100)

0 (0)

7 (100)

0 (0)

3 (100)

0 (0)

33 (89.2)

4 (10.8)

2

MR signal increase from regional lymph nodes

yes

no

33 (100)

0 (0)

18 (100)

0 (0)

0 (0)

7 (100)

3 (100)

0 (0)

37 (100)

0 (0)

3

MR signal increase from distant lymph nodes

yes

no

33 (100)

0 (0)

18 (100)

0 (0)

0 (0)

7 (100)

3 (100)

0 (0)

37 (100)

0 (0)

4

External contours of urinary bladder wall

smooth

rough

33 (100)

0 (0)

17 (94.4)

1 (5.6)

0 (0)

7 (100)

0 (0)

3 (100)

37 (100)

0 (0)

 

In the comparison group signal increase from the urinary bladder wall was not observed in 4 patients (10.8%). During DWIBS investigation of the patients with stage T2 of UBC irregular external bladder wall contours in the area of the malformation (false MR sign of the formation spread into the paravesical fat) were detected in 1 patient (5.6%), while during MR investigation - in 6 patients (33.3%) (Fig. 3).

The results of the carried out investigation demonstrate that DWIBS study sensitivity in detecting urinary bladder cancer is 98.4%, specificity – 10.8%, diagnostic effectiveness of the method – 65.4%.

Figure 3. MR investigation: T2 WI-image (a) and DWIBS-image (b). The arrow indicates bladder wall formations, which has a homogeneous structure (T2 stage according TNM). External contours of wall formations is rough on T2 WI –image (signs distribution in perivesical tissue) and is smooth on DWIBS-image (no signs distribution in perivesical tissue).

 

Discussion

For a long time diffusion magnetic resonance tomography (DMRT) was used only for investigation of the brain.

Extracranial DMRT was complicated by multiple artefacts from the movement and magnetic receptivity which resulted in the loss if diagnostic significance of the given investigation [2]. Increase of gradients and appearance of new multichannel rolls almost solved that problem, but up to the recent time extracranial DMRT was obligatorily carried out at the breath holding, because respirarory movements were the obstacles for DWI due to the shifts during the internal organs respiration [4].

T. Takahara et al. in 2004 reported about a new unique conception of the whole body DWI called "diffusion-weighted imaging of the whole body with the background body signal suppression" (DWIBS) [5]. Most researchers report that DWIBS investigation is a means for detecting lymphatic nodes independently of their histological composition [5, 6]. The present study supports this viewpoint.

The results of the carried out study show that sensitivity of DWIBS investigation in detecting bladder cancer is high (98.4%) but low specificity parameters (10.8%) allow to judge rather about screening role of the given technique in complex diagnostics of the urinary bladder cancer.Rather significant results of the investigation, to our opinion, are relevant differences in detecting MR signs during DWIBS investigation and routine MRT of false spread of the bladder wall formation into the paravesical fat, which allows to differentiate stages T2 and T3 of the urinary bladder cancer.

Evaluation of the bladder neoplasm, possible regional and distant metastases allows to consider another way of potential DWIBS application - as the means of radiation- and chemotherapy effectiveness evaluation. DWIBS investigation makes it possible to visualize the signs and characteristics of the detected areas of alterated diffusion and to reveal pre-structural frunctional changes associated with the tumour [7].

 

Conclusions

DWIBS investigation in a number of cases verifies stages of the pathological process, i.e. allows to differentiate stages T2 and T3 of the urinary bladder cancer. Considering high sensitivity and low specificity of DWIBS investigation the described noninvasive informative technique could be used, basically, in screening diagnostics of UBC and in determining indications for expansive anatomical magnetic resonance tomography.

 

Conflict of interest: none declared.

References: 
  1. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics 2006; 26(2): 553–580 (PMID: 16549617) (doi: 10.1148/rg.262055172).
  2. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with single-shot echoplanar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 1999; 24(5): 456–461 (doi: 10.1007/s002619900539) (PMID: 10475927).
  3. Kwee TC, Takahara T, Ochiai R, Nievelstein RAJ, Luijten PR. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18(9): 1937–1952 (doi:  10.1007/s00330-008-0968-z) (PMCID: PMC2516183).
  4. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007; 25(4): 848–858 (PMID: 17335018) (doi: 10.1002/jmri.20864).
  5. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22(4): 275–282 (PMID: 15468951).
  6. Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, Tekkis PP. Diagnostic precision of nanoparticle-enhanced MRI for lymphnode metastases: a meta-analysis. Lancet Oncol 2006; 7(1): 52–60 (PMID: 16389184) (doi: 10.1016/S1470-2045(05)70537-4).
  7. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007; 25(26): 4104–4109 (doi: 10.1200/JCO.2007.11.9610) (PMID: 17827460).
About the Authors: 

Vladimir M. Popkov — MD, D.Sc., Head of Department of Urology, Rector of Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia;

M.L. Chekhonatskaya — MD, D.Sc., Professor, Head of Department of Roentgen Diagnostics, Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia;

Viktor V. Zuev — MD, Senior Research Assistant, Department of Roentgen Diagnostics, Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia;

A.N. Ponukalin — MD, PhD, Assistant Professor, Department of Urology, Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia;

Y.E. Nikolsky — MD, Senior Research Assistant, Department of Roentgen Diagnostics, Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia.

Accepted 20 July 2012

Original Text in Russian © Popkov VM, Chekhonatskaya ML, Zuev VV, Ponukalin AN, Nikolsky YE, 2011, published in Saratov Journal of Medical Scientific Research 2011; 7(4): 941–946.

Correspondence to Viktor V. Zuev. Address: room 10, 12, Tulupnaya str., Saratov, 410031, Russia. Phone: +7-8452-281724. E-mail: zuev.viktor.sgmu@gmail.com

DOI: 
10.15275/rusomj.2012.0210